Related Experiment Video

Updated: Aug 24, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes

Robert J McCarter1, James M Hempe, Ricardo Gomez

  • 1Endocrinology/Diabetes, Children's Hospital of New Orleans, 200 Henry Clay Avenue, New Orleans, LA 70118, USA.

Diabetes Care
|May 27, 2004
PubMed

Insights

Biological variation in hemoglobin A1c (HbA1c), independent of mean blood glucose, predicts microvascular complications in type 1 diabetes. This finding could lead to new therapies for preventing diabetes complications.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetology

Background:

  • Hemoglobin A1c (HbA1c) is a key marker for glycemic control in diabetes.
  • Biological variation in HbA1c, beyond mean blood glucose (MBG), may influence complication risk.

Purpose of the Study:

  • To investigate if biological variation in HbA1c predicts microvascular complications in type 1 diabetes.
  • To determine if HbA1c variability, independent of MBG, is associated with retinopathy and nephropathy risk.

Main Methods:

  • Developed a longitudinal regression model using MBG and HbA1c from 1,441 participants in the Diabetes Control and Complications Trial (DCCT).
  • Calculated a hemoglobin glycation index (HGI) to quantify biological variation in HbA1c.
  • Used Cox proportional hazard analysis to compare complication risks between HGI groups.

Main Results:

  • HbA1c levels were not solely determined by MBG, indicating significant biological variation.
  • High-HGI individuals (higher-than-predicted HbA1c) had a threefold increased risk of retinopathy.
  • High-HGI individuals had a sixfold increased risk of nephropathy compared to low-HGI individuals.

Conclusions:

  • Biological variation in HbA1c is a significant predictor of microvascular complications in type 1 diabetes.
  • Understanding the mechanisms behind HbA1c variability may reveal novel therapeutic targets.
  • These findings suggest potential for new treatments beyond glucose-lowering strategies.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...